Index of reports
> Cases with Neuroleptic Malignant Syndrome ()
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Risperdal (Risperidone) where reactions include neuroleptic malignant syndrome. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of Next >>
Possible Risperdal side effects in 31 year old male
Reported by a pharmacist from Japan on 2012-08-27
Patient: 31 year old male, weighing 59.0 kg (129.8 pounds)
Reactions: Eosinophilic Pneumonia, Pulmonary Alveolar Haemorrhage, Acute Respiratory Distress Syndrome, Neuroleptic Malignant Syndrome, Pneumonia Staphylococcal
Adverse event resulted in: death
Drug(s) suspected as cause:
Abilify
Administration route: Oral
Indication: Schizophrenia
Start date: 2012-06-23
End date: 2012-06-29
Levotomin
Administration route: Oral
Indication: Schizophrenia
Start date: 2012-06-01
End date: 2012-06-29
Methotrimeprazine Maleate
Risperdal
Dosage: 4mg: 4jun-11jun12(8days) 2mg:12jun-29jun12(18days)
Administration route: Oral
Indication: Schizophrenia
Start date: 2012-06-04
End date: 2012-06-29
Rohypnol
Administration route: Oral
Indication: Schizophrenia
Start date: 2012-06-01
End date: 2012-06-29
Other drugs received by patient: Diazepam; Promethazine HCL; Miya-BM
Possible Risperdal side effects in 31 year old male
Reported by a physician from Japan on 2012-08-27
Patient: 31 year old male, weighing 59.0 kg (129.8 pounds)
Reactions: Eosinophilic Pneumonia, Pulmonary Alveolar Haemorrhage, Acute Respiratory Distress Syndrome, Neuroleptic Malignant Syndrome, Pneumonia Staphylococcal
Adverse event resulted in: death
Drug(s) suspected as cause:
Abilify
Administration route: Oral
Indication: Schizophrenia
Start date: 2012-06-23
End date: 2012-06-29
Levotomin
Administration route: Oral
Indication: Schizophrenia
Start date: 2012-06-01
End date: 2012-06-29
Methotrimeprazine Maleate
Risperdal
Dosage: 4mg: 4jun-11jun12(8days) 2mg:12jun-29jun12(18days)
Administration route: Oral
Indication: Schizophrenia
Start date: 2012-06-04
End date: 2012-06-29
Rohypnol
Administration route: Oral
Indication: Schizophrenia
Start date: 2012-06-01
End date: 2012-06-29
Other drugs received by patient: Diazepam; Promethazine HCL; Miya-BM
Possible Risperdal side effects in 31 year old male
Reported by a consumer/non-health professional from Japan on 2012-08-16
Patient: 31 year old male, weighing 59.0 kg (129.8 pounds)
Reactions: Eosinophilic Pneumonia, Pulmonary Alveolar Haemorrhage, Acute Respiratory Distress Syndrome, Pneumonia Staphylococcal, Neuroleptic Malignant Syndrome
Adverse event resulted in: death
Drug(s) suspected as cause:
Abilify
Administration route: Oral
Indication: Schizophrenia
Start date: 2012-06-23
End date: 2012-06-29
Levotomin
Administration route: Oral
Start date: 2012-06-01
Methotrimeprazine Maleate
Risperdal
Dosage: 4mg: 4jun-11jun12(8days) 2mg:12jun-29jun12(18days)
Administration route: Oral
Indication: Schizophrenia
Start date: 2012-06-04
End date: 2012-06-29
Rohypnol
Start date: 2012-06-01
Other drugs received by patient: Promethazine HCL; Miya-BM; Diazepam
Possible Risperdal side effects in 31 year old male
Reported by a pharmacist from Japan on 2012-08-03
Patient: 31 year old male
Reactions: Eosinophilic Pneumonia, Haemorrhage, Interstitial Lung Disease, Neuroleptic Malignant Syndrome
Adverse event resulted in: death
Drug(s) suspected as cause:
Abilify
Administration route: Oral
Indication: Schizophrenia
Start date: 2012-06-23
End date: 2012-07-02
Haloperidol
Administration route: Oral
Indication: Schizophrenia
Start date: 2012-06-01
End date: 2012-07-02
Risperdal
Administration route: Oral
Indication: Schizophrenia
Start date: 2012-06-29
End date: 2012-07-02
Risperdal
Administration route: Oral
Start date: 2012-06-04
End date: 2012-06-29
Possible Risperdal side effects in 31 year old male
Reported by a consumer/non-health professional from Japan on 2012-08-02
Patient: 31 year old male, weighing 59.0 kg (129.8 pounds)
Reactions: Eosinophilic Pneumonia, Pulmonary Alveolar Haemorrhage, Acute Respiratory Distress Syndrome, Pneumonia Staphylococcal, Neuroleptic Malignant Syndrome
Adverse event resulted in: death
Drug(s) suspected as cause:
Abilify
Administration route: Oral
Indication: Schizophrenia
Start date: 2012-06-23
End date: 2012-06-29
Levotomin
Administration route: Oral
Start date: 2012-06-01
Risperdal
Dosage: 4mg: 4jun-11jun12(8days) 2mg:12jun-29jun12(18days)
Administration route: Oral
Indication: Schizophrenia
Start date: 2012-06-04
End date: 2012-06-29
Other drugs received by patient: Miya-BM; Promethazine HCL; Rohypnol; Diazepam
Possible Risperdal side effects in
Reported by a pharmacist from Japan on 2012-07-30
Patient:
Reactions: Neuroleptic Malignant Syndrome
Drug(s) suspected as cause:
Keppra
Administration route: Oral
Risperdal
Possible Risperdal side effects in 57 year old female
Reported by a physician from Peru on 2012-07-23
Patient: 57 year old female
Reactions: Injection Site Abscess, Sensory Disturbance, Neuroleptic Malignant Syndrome, Injection Site Infection
Drug(s) suspected as cause:
Risperdal
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Risperdal Consta
Indication: Product Used FOR Unknown Indication
Possible Risperdal side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-06-29
Patient: female
Reactions: Incorrect Route of Drug Administration, Mutism, Hyperkalaemia, Encephalitis, Hepatic Failure, Multi-Organ Failure, Acute Respiratory Distress Syndrome, Neuroleptic Malignant Syndrome, Gastrointestinal Obstruction, Renal Failure Acute, Hypertriglyceridaemia, Clonus, Cytolytic Hepatitis, Status Epilepticus, Convulsion, Cardiac Failure, Encephalitis Autoimmune, Septic Shock
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Citalopram Hydrobromide
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2009-02-01
End date: 2010-08-13
Gardasil
Dosage: injectable suspension. human papilloma virus vaccine [types 6, 11, 16, 18] (recombinant, adsorbed)
Indication: Immunisation
Start date: 2008-12-01
End date: 2009-04-01
Risperdal
Indication: Product Used FOR Unknown Indication
Start date: 2010-08-01
End date: 2010-08-13
Tercian
Dosage: dose : 50 mg/ 5 ml
Indication: Product Used FOR Unknown Indication
Start date: 2010-08-01
End date: 2010-08-13
Other drugs received by patient: Lorazepam
Possible Risperdal side effects in female
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-06-26
Patient: female
Reactions: Off Label Use, Encephalitis Autoimmune, Neuroleptic Malignant Syndrome
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Citalopram Hydrobromide
Dosage: 10 mg
Administration route: Oral
Start date: 2009-02-01
End date: 2010-08-13
Gardasil
Indication: Immunisation
Start date: 2008-12-01
End date: 2009-04-01
Risperdal
Start date: 2010-08-01
End date: 2010-08-13
Tercian
Start date: 2010-08-01
End date: 2010-08-13
Other drugs received by patient: Lorazepam
Possible Risperdal side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-06-25
Patient: female
Reactions: Incorrect Route of Drug Administration, Hyperkalaemia, Mutism, Encephalitis, Hepatic Failure, Multi-Organ Failure, Acute Respiratory Distress Syndrome, Neuroleptic Malignant Syndrome, Renal Failure Acute, Hypertriglyceridaemia, Gastrointestinal Obstruction, Cytolytic Hepatitis, Clonus, Status Epilepticus, Convulsion, Cardiac Failure, Encephalitis Autoimmune, Septic Shock
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Citalopram Hydrobromide
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2009-02-01
End date: 2010-08-13
Gardasil
Dosage: injectable suspension. human papilloma virus vaccine [types 6, 11, 16, 18] (recombinant, adsorbed)
Indication: Immunisation
Start date: 2008-12-01
End date: 2009-04-01
Risperdal
Indication: Product Used FOR Unknown Indication
Start date: 2010-08-01
End date: 2010-08-13
Tercian
Dosage: dose : 50 mg/ 5 ml
Indication: Product Used FOR Unknown Indication
Start date: 2010-08-01
End date: 2010-08-13
Other drugs received by patient: Lorazepam
Possible Risperdal side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-06-20
Patient: female
Reactions: Incorrect Route of Drug Administration, Mutism, Hyperkalaemia, Encephalitis, Hepatic Failure, Multi-Organ Failure, Acute Respiratory Distress Syndrome, Neuroleptic Malignant Syndrome, Gastrointestinal Obstruction, Hypertriglyceridaemia, Renal Failure Acute, Cytolytic Hepatitis, Clonus, Status Epilepticus, Convulsion, Cardiac Failure, Encephalitis Autoimmune, Septic Shock
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Citalopram
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2009-02-01
End date: 2010-08-13
Risperdal
Indication: Product Used FOR Unknown Indication
Start date: 2010-08-01
End date: 2010-08-13
Tercian
Dosage: dose : 50 mg/ 5 ml
Indication: Product Used FOR Unknown Indication
Start date: 2010-08-01
End date: 2010-08-13
Other drugs received by patient: Lorazepam; Gardasil
Possible Risperdal side effects in male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-06-04
Patient: male, weighing 57.0 kg (125.4 pounds)
Reactions: Pneumonia, Staphylococcal Infection, Sepsis, Malnutrition, Neuroleptic Malignant Syndrome
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Risperdal
Administration route: Oral
Indication: Schizophrenia
Risperdal Consta
Indication: Schizophrenia
Start date: 2011-06-18
Possible Risperdal side effects in 76 year old female
Reported by a physician from Japan on 2012-05-30
Patient: 76 year old female, weighing 53.0 kg (116.6 pounds)
Reactions: Pulmonary Haemorrhage, Cardio-Respiratory Arrest, Respiratory Failure, Pulmonary Embolism, Neuroleptic Malignant Syndrome, Deep Vein Thrombosis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Risperdal
Dosage: 3-10 mg/day
Administration route: Oral
Start date: 2003-10-16
End date: 2011-06-20
Risperdal
Dosage: 3-10 mg/day
Administration route: Oral
Indication: Schizophrenia
Start date: 2003-10-16
End date: 2011-06-20
Other drugs received by patient: Cibenol; Parlodel; Rohypnol; Lonasen
Possible Risperdal side effects in 49 year old male
Reported by a physician from Japan on 2012-05-24
Patient: 49 year old male
Reactions: Overdose, Neuroleptic Malignant Syndrome, Drug Prescribing Error, Blood Glucose Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Invega
Administration route: Oral
Indication: Schizophrenia
Start date: 2011-04-22
End date: 2011-05-05
Risperdal
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Hirnamine; Phenobarbital TAB; Rhythmy; Bepotastine Besilate; Phenobarbital TAB; Nitrazepam; Hirnamine; Lexotan; Akineton; Clonazepam
Possible Risperdal side effects in male
Reported by a pharmacist from Japan on 2012-04-23
Patient: male
Reactions: Neuroleptic Malignant Syndrome
Drug(s) suspected as cause:
Casodex
Administration route: Oral
Risperdal
Zoladex
Possible Risperdal side effects in female
Reported by a physician from Germany on 2012-04-16
Patient: female, weighing 110.0 kg (242.0 pounds)
Reactions: Partial Seizures, Tachycardia, Suicide Attempt, Meningitis, Pyrexia, Neuroleptic Malignant Syndrome, Serotonin Syndrome, Sopor
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
AN Unknown Medication
Administration route: Oral
Indication: Product Used FOR Unknown Indication
AN Unknown Medication
Administration route: Oral
Citalopram
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Citalopram
Administration route: Oral
Lorazepam
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Lorazepam
Administration route: Oral
Risperdal
Administration route: Oral
Risperdal
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Possible Risperdal side effects in 76 year old female
Reported by a physician from Japan on 2012-04-04
Patient: 76 year old female, weighing 53.0 kg (116.6 pounds)
Reactions: Pulmonary Haemorrhage, Respiratory Failure, Pulmonary Embolism, Neuroleptic Malignant Syndrome, Deep Vein Thrombosis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Risperdal
Other drugs received by patient: Cibenol; Lonasen; Parlodel; Rohypnol
Possible Risperdal side effects in female
Reported by a physician from Germany on 2012-04-02
Patient: female, weighing 110.0 kg (242.0 pounds)
Reactions: Partial Seizures, Suicide Attempt, Meningitis, Serotonin Syndrome, Neuroleptic Malignant Syndrome, Pyrexia, Sopor
Drug(s) suspected as cause:
AN Unknown Medication
Administration route: Oral
AN Unknown Medication
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Citalopram Hydrobromide
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Citalopram Hydrobromide
Administration route: Oral
Lorazepam
Administration route: Oral
Lorazepam
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Risperdal
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Risperdal
Administration route: Oral
Possible Risperdal side effects in 76 year old female
Reported by a physician from Japan on 2012-03-23
Patient: 76 year old female, weighing 53.0 kg (116.6 pounds)
Reactions: Pulmonary Haemorrhage, Respiratory Failure, Pulmonary Embolism, Neuroleptic Malignant Syndrome, Deep Vein Thrombosis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Risperdal
Other drugs received by patient: Rohypnol; Parlodel; Cibenol; Lonasen
Possible Risperdal side effects in 13 year old female
Reported by a pharmacist from France on 2012-03-08
Patient: 13 year old female
Reactions: Neuroleptic Malignant Syndrome, Liver Disorder
Drug(s) suspected as cause:
Risperdal
Administration route: Oral
End date: 2012-02-18
Risperdal
Dosage: 0.5-0.5-1mg
Administration route: Oral
Indication: Mania
Start date: 2012-02-14
Possible Risperdal side effects in male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-03-06
Patient: male, weighing 57.0 kg (125.4 pounds)
Reactions: Pneumonia, Staphylococcal Infection, Malnutrition, Sepsis, Neuroleptic Malignant Syndrome
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Risperdal
Administration route: Oral
Indication: Schizophrenia
Risperdal Consta
Indication: Schizophrenia
Start date: 2011-06-18
Possible Risperdal side effects in female
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-03-01
Patient: female
Reactions: Off Label Use, Neuroleptic Malignant Syndrome
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Citalopram Hydrobromide
Dosage: 10 mg
Administration route: Oral
Start date: 2009-02-01
End date: 2010-08-13
Risperdal
Start date: 2010-08-01
End date: 2010-08-13
Tercian
Start date: 2010-08-01
End date: 2010-08-13
Other drugs received by patient: Lorazepam; Gardasil
Possible Risperdal side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-02-27
Patient: female
Reactions: Atelectasis, Incorrect Route of Drug Administration, Mutism, Hyperkalaemia, Hepatic Failure, Encephalitis, Multi-Organ Failure, Acute Respiratory Distress Syndrome, Neuroleptic Malignant Syndrome, Hypertriglyceridaemia, Gastrointestinal Obstruction, Renal Failure Acute, Autonomic Nervous System Imbalance, Cytolytic Hepatitis, Pseudomonas Infection, Clonus, Status Epilepticus, Haemodialysis, Convulsion, Cardiac Failure, Septic Shock
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Citalopram Hydrobromide
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2009-02-01
End date: 2010-08-13
Risperdal
Indication: Product Used FOR Unknown Indication
Start date: 2010-08-01
End date: 2010-08-13
Tercian
Dosage: dose : 50 mg/ 5 ml
Indication: Product Used FOR Unknown Indication
Start date: 2010-08-01
End date: 2010-08-13
Other drugs received by patient: Lorazepam; Gardasil
Possible Risperdal side effects in male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-02-24
Patient: male, weighing 57.0 kg (125.4 pounds)
Reactions: Pneumonia, Staphylococcal Infection, Malnutrition, Sepsis, Neuroleptic Malignant Syndrome
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Risperdal
Administration route: Oral
Indication: Schizophrenia
Risperdal Consta
Indication: Schizophrenia
Start date: 2011-06-18
Possible Risperdal side effects in 82 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-01-11
Patient: 82 year old female
Reactions: Anxiety, Overdose, Renal Failure, Folate Deficiency, Hypoxia, Neuroleptic Malignant Syndrome, Hypocapnia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Risperdal
Other drugs received by patient: Oxazepam; Zolpidem; Oxazepam; Valsartan and Hydrochlorothiazide; Lorazepam; Amlodipine Besylate; Lorazepam; Lithium Carbonate; Effexor
Possible Risperdal side effects in 14 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2011-12-22
Patient: 14 year old female
Reactions: Myalgia, Hyperthermia, Sepsis, Hypotension, Neuroleptic Malignant Syndrome
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Risperdal
Possible Risperdal side effects in male
Reported by a health professional (non-physician/pharmacist) from Japan on 2011-12-07
Patient: male, weighing 57.0 kg (125.4 pounds)
Reactions: Pneumonia, Staphylococcal Infection, Malnutrition, Sepsis, Neuroleptic Malignant Syndrome
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Risperdal
Administration route: Oral
Indication: Schizophrenia
Risperdal Consta
Indication: Schizophrenia
Start date: 2011-06-18
Possible Risperdal side effects in female
Reported by a health professional (non-physician/pharmacist) from Japan on 2011-12-02
Patient: female, weighing 51.0 kg (112.2 pounds)
Reactions: Hepatic Function Abnormal, Disseminated Intravascular Coagulation, Sepsis, Neuroleptic Malignant Syndrome
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Lonasen
Administration route: Oral
Start date: 2010-02-25
End date: 2010-06-28
Lonasen
Administration route: Oral
Indication: Schizophrenia
Start date: 2010-01-27
End date: 2010-02-25
Lonasen
Administration route: Oral
Start date: 2009-12-21
End date: 2010-01-27
Risperdal
Administration route: Oral
Start date: 2008-06-12
End date: 2008-07-11
Risperdal
Administration route: Oral
Start date: 2008-11-13
End date: 2008-12-04
Risperdal
Administration route: Oral
Indication: Schizophrenia
Start date: 2008-12-04
End date: 2009-12-25
Risperdal
Administration route: Oral
Start date: 2008-07-25
End date: 2008-08-08
Risperdal
Administration route: Oral
Start date: 2008-07-11
End date: 2008-07-25
Risperdal
Administration route: Oral
Start date: 2008-08-08
End date: 2008-11-13
Risperdal
Administration route: Oral
Start date: 2009-12-28
End date: 2010-04-28
Risperdal
Administration route: Oral
Start date: 2010-04-28
End date: 2010-06-28
Rohypnol
Administration route: Oral
Start date: 2009-08-27
End date: 2010-04-27
Rohypnol
Administration route: Oral
Start date: 2010-05-31
End date: 2010-06-24
Rohypnol
Administration route: Oral
Start date: 2008-06-27
End date: 2008-07-24
Rohypnol
Administration route: Oral
Indication: Insomnia
Start date: 2009-07-02
End date: 2009-08-26
Rohypnol
Administration route: Oral
Start date: 2008-07-25
End date: 2008-08-07
Rohypnol
Administration route: Oral
Start date: 2008-10-23
End date: 2009-01-07
Rohypnol
Administration route: Oral
Start date: 2008-06-20
End date: 2008-06-26
Rohypnol
Administration route: Oral
Start date: 2009-06-04
End date: 2009-07-01
Rohypnol
Administration route: Oral
Start date: 2009-01-08
End date: 2009-05-06
Rohypnol
Administration route: Oral
Start date: 2008-10-02
End date: 2008-10-22
Rohypnol
Administration route: Oral
Start date: 2010-04-28
End date: 2010-05-15
Rohypnol
Administration route: Oral
Start date: 2010-06-25
End date: 2010-06-28
Rohypnol
Administration route: Oral
Start date: 2008-08-08
End date: 2008-10-01
Other drugs received by patient: Akineton; Depas; NON-Pyrine Cold Preparation; Abilify; Akineton; Akineton; Akineton; Akineton; Mycosporan; Akineton; Akineton; Akineton; Akineton; Ephedra Teas
Possible Risperdal side effects in 64 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2011-11-23
Patient: 64 year old male
Reactions: Pneumonia, Staphylococcal Infection, Malnutrition, Neuroleptic Malignant Syndrome
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Risperdal
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Risperdal Consta
Indication: Product Used FOR Unknown Indication
Start date: 2011-06-18
Possible Risperdal side effects in 78 year old female
Reported by a physician from Germany on 2011-11-11
Patient: 78 year old female
Reactions: Blood Creatine Phosphokinase Increased, Rhabdomyolysis, Neuroleptic Malignant Syndrome, Lactic Acidosis
Drug(s) suspected as cause:
Livalo
Metformin HCL
Dosage: initially 500mg per day
Administration route: Oral
Indication: Diabetes Mellitus
Risperdal
Other drugs received by patient: Candesartan Cilexetil; Amaryl
Page 1 Next >>
|